For many of the most important mediators identified in predictive models of COVID-19 severity, concentrations appeared divergent early and throughout the course of symptoms, including IL-7, IL-10, lymphotoxin-α, TGF-α, VEGF-A, and MDC (Fig. 3a). This evidence concerns the gene CCL22 and COVID-19.